• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
UCM 0.00% 3.2¢

USCOM LIMITED - Announcements

Uscom Limited is a medical technology company. It specializes in the development and... Uscom Limited is a medical technology company. It specializes in the development and marketing of non-invasive cardiovascular and pulmonary medical devices. It has three suites of devices in the field of cardiac, vascular, and pulmonary monitoring: the USCOM 1A advanced haemodynamic monitor, Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers. The USCOM 1A is a non-invasive advanced haemodynamic monitor that measures cardiovascular function, detects irregularities, and is used to guide treatment. The USCOM 1A device has applications in emergency, intensive care medicine and anesthesia. The Uscom BP+ is a supra-systolic oscillometric central blood pressure monitor which measures blood pressure and blood pressure waveforms in the heart, as well as in the arm, information only previously available using invasive cardiac catheterization. Its VENTITEST digital ultrasonic ventilator testing solution is a new system for testing ventilators.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

Filters [Clear]
  • Price Sensitive: Yes
UCMTrading HaltPRICE SENSITIVE13/05/14
UCMUscom receives new US Patent notification for BP monitorPRICE SENSITIVE12/05/14
UCMAppendix 4C - quarterlyPRICE SENSITIVE28/04/14
UCMUscom appoints new European distributorPRICE SENSITIVE27/02/14
UCMUscom BP new hypertension gold standard in childrenPRICE SENSITIVE24/02/14
UCMHalf Yearly Report and AccountsPRICE SENSITIVE21/02/14
UCMUscom BP leading blood pressure technology - Global studyPRICE SENSITIVE10/02/14
UCMUscom BP receives CE Mark for sales into EuropePRICE SENSITIVE04/02/14
UCMUscom appoints Deltex to distribution teamPRICE SENSITIVE29/01/14
UCMAppendix 4C - quarterlyPRICE SENSITIVE29/01/14
UCMAppendix 4C - quarterlyPRICE SENSITIVE28/10/13
UCMUscom signs 5 year $7m China sales dealPRICE SENSITIVE15/10/13
UCMSuccessful capital raising to support new sales initiativesPRICE SENSITIVE18/09/13
UCMPreliminary and Annual Report to shareholdersPRICE SENSITIVE30/08/13
UCMAppendix 4C - quarterlyPRICE SENSITIVE26/07/13
UCMUscom Announces Italian Distribution Deal with VegaPRICE SENSITIVE25/06/13
UCMUscom Completes Pulsecor Asset PurchasePRICE SENSITIVE18/06/13
UCMUscom to Acquire Pulsecor and New Blood Pressure ProductsPRICE SENSITIVE30/05/13
UCMNew USCOM Method for Measurement of Heart FunctionPRICE SENSITIVE08/05/13
UCMUSCOM Strategic Focus - New Distribution in MexicoPRICE SENSITIVE01/05/13
UCMAppendix 4C - quarterlyPRICE SENSITIVE26/04/13
UCMHalf Yearly Report and AccountsPRICE SENSITIVE27/02/13
UCMReduction in Sepsis Deaths and Hospital Costs Using USCOMPRICE SENSITIVE22/01/13
UCMAppendix 4C - quarterlyPRICE SENSITIVE22/01/13
UCMUSCOM more accurate monitor than blood pressure in pregnancyPRICE SENSITIVE23/10/12
UCMAppendix 4C - quarterlyPRICE SENSITIVE17/10/12
UCMRole for USCOM in cancer treatmentPRICE SENSITIVE24/09/12
UCMSophisticated investors oversubscribe to Uscom placementPRICE SENSITIVE05/09/12
UCMPreliminary and Annual Report to shareholdersPRICE SENSITIVE30/08/12
UCMUscom opens private placement fully subscribedPRICE SENSITIVE20/08/12
UCMResponse to ASX Appendix 4C QueryPRICE SENSITIVE02/08/12
UCMUSCOM used to reduce mortality in septic shock by 90%PRICE SENSITIVE02/08/12
UCMAppendix 4C - quarterlyPRICE SENSITIVE27/07/12
UCMNew Substantial shareholdingPRICE SENSITIVE20/07/12
UCMGerman study endorses USCOMPRICE SENSITIVE05/06/12
UCMNew UK NHS GuidelinesPRICE SENSITIVE11/05/12
UCMAppendix 4C CommentaryPRICE SENSITIVE02/05/12
UCMAppendix 4C - quarterlyPRICE SENSITIVE30/04/12
UCMUSCOM expands distributionPRICE SENSITIVE19/03/12
UCMHalf Yearly Report and AccountsPRICE SENSITIVE23/02/12
UCMAppendix 4C - quarterlyPRICE SENSITIVE31/01/12
UCMManagement restructure and operations updatePRICE SENSITIVE07/12/11
UCMBoard AppointmentsPRICE SENSITIVE25/11/11
UCMTrading HaltPRICE SENSITIVE23/11/11
UCMAppendix 4C - quarterlyPRICE SENSITIVE31/10/11
UCMPreliminary and Annual Report to shareholdersPRICE SENSITIVE31/08/11
UCMAppendix 4C - quarterlyPRICE SENSITIVE27/07/11
UCMUpdate on Full Year ResultsPRICE SENSITIVE13/07/11
UCMUscom advances into EuropePRICE SENSITIVE13/05/11
UCMAppendix 4C - quarterlyPRICE SENSITIVE29/04/11
UCMNew sales distributors in USA and CanadaPRICE SENSITIVE13/04/11
UCMHalf Yearly Report and AccountsPRICE SENSITIVE24/02/11
UCMHalf year financial updatePRICE SENSITIVE27/01/11
UCMAppendix 4C - quarterlyPRICE SENSITIVE27/01/11
UCMUSCOM Share purchase planPRICE SENSITIVE19/01/11
UCMFinancial results updatePRICE SENSITIVE14/01/11
UCMKiely appointment and proposed private placementPRICE SENSITIVE02/12/10
UCMAppendix 4C - quarterlyPRICE SENSITIVE29/10/10
UCMPreliminary and Annual Report to shareholdersPRICE SENSITIVE31/08/10
UCMStrategic Review of Sales and Distribution ChannelsPRICE SENSITIVE20/08/10
UCMAppendix 4C - quarterlyPRICE SENSITIVE20/07/10
UCMNew US Patent for UscomPRICE SENSITIVE27/04/10
UCMAppendix 4C - quarterlyPRICE SENSITIVE20/04/10
UCMCanadian Regulatory Approval for USCOMPRICE SENSITIVE06/04/10
UCMUSCOM publication on ICU fluid and septic shockPRICE SENSITIVE18/03/10
UCMHalf Yearly Report and AccountsPRICE SENSITIVE09/02/10
UCMAppendix 4C - quarterlyPRICE SENSITIVE27/01/10
UCMPresented at Rome Congress and European Users MeetingPRICE SENSITIVE21/12/09
UCMTexas Childrens Hospital Adopts USCOM TechnologyPRICE SENSITIVE19/11/09
UCMAppendix 4C - quarterlyPRICE SENSITIVE20/10/09
UCMSpacelabs Healthcare to Launch Uscom in the UKPRICE SENSITIVE25/09/09
UCMUSCOM Allowed USA Pacemaker Optimisation PatentPRICE SENSITIVE04/09/09
UCMPreliminary and Annual Report to shareholdersPRICE SENSITIVE28/08/09
UCMAppendix 4C - quarterlyPRICE SENSITIVE28/07/09
UCMFY09 UpdatePRICE SENSITIVE06/07/09
UCMFurther 24 USCOM units ordered by Spacelabs HealthcarePRICE SENSITIVE22/06/09
UCMUSCOM validated in pregnancyPRICE SENSITIVE20/04/09
UCMAppendix 4C - quarterlyPRICE SENSITIVE20/04/09
UCMHalf Yearly Report and AccountsPRICE SENSITIVE27/02/09
UCMAppendix 4C - quarterlyPRICE SENSITIVE27/01/09
UCMEchoscope - New US patent for UscomPRICE SENSITIVE14/01/09
UCMUSCOM - American Journal of Surgery PublicationPRICE SENSITIVE18/12/08
UCMStrategic Investment by NASDAQ Listed OSI SystemsPRICE SENSITIVE17/12/08
UCMUscom and Spacelabs Healthcare form strategic relationshipPRICE SENSITIVE16/12/08
UCMTrading Halt
13/05/14PRICE SENSITIVE
UCMUscom receives new US Patent notification for BP monitor
12/05/14PRICE SENSITIVE
UCMAppendix 4C - quarterly
28/04/14PRICE SENSITIVE
UCMUscom appoints new European distributor
27/02/14PRICE SENSITIVE
UCMUscom BP new hypertension gold standard in children
24/02/14PRICE SENSITIVE
UCMHalf Yearly Report and Accounts
21/02/14PRICE SENSITIVE
UCMUscom BP leading blood pressure technology - Global study
10/02/14PRICE SENSITIVE
UCMUscom BP receives CE Mark for sales into Europe
04/02/14PRICE SENSITIVE
UCMUscom appoints Deltex to distribution team
29/01/14PRICE SENSITIVE
UCMAppendix 4C - quarterly
29/01/14PRICE SENSITIVE
UCMAppendix 4C - quarterly
28/10/13PRICE SENSITIVE
UCMUscom signs 5 year $7m China sales deal
15/10/13PRICE SENSITIVE
UCMSuccessful capital raising to support new sales initiatives
18/09/13PRICE SENSITIVE
UCMPreliminary and Annual Report to shareholders
30/08/13PRICE SENSITIVE
UCMAppendix 4C - quarterly
26/07/13PRICE SENSITIVE
UCMUscom Announces Italian Distribution Deal with Vega
25/06/13PRICE SENSITIVE
UCMUscom Completes Pulsecor Asset Purchase
18/06/13PRICE SENSITIVE
UCMUscom to Acquire Pulsecor and New Blood Pressure Products
30/05/13PRICE SENSITIVE
UCMNew USCOM Method for Measurement of Heart Function
08/05/13PRICE SENSITIVE
UCMUSCOM Strategic Focus - New Distribution in Mexico
01/05/13PRICE SENSITIVE
UCMAppendix 4C - quarterly
26/04/13PRICE SENSITIVE
UCMHalf Yearly Report and Accounts
27/02/13PRICE SENSITIVE
UCMReduction in Sepsis Deaths and Hospital Costs Using USCOM
22/01/13PRICE SENSITIVE
UCMAppendix 4C - quarterly
22/01/13PRICE SENSITIVE
UCMUSCOM more accurate monitor than blood pressure in pregnancy
23/10/12PRICE SENSITIVE
UCMAppendix 4C - quarterly
17/10/12PRICE SENSITIVE
UCMRole for USCOM in cancer treatment
24/09/12PRICE SENSITIVE
UCMSophisticated investors oversubscribe to Uscom placement
05/09/12PRICE SENSITIVE
UCMPreliminary and Annual Report to shareholders
30/08/12PRICE SENSITIVE
UCMUscom opens private placement fully subscribed
20/08/12PRICE SENSITIVE
UCMResponse to ASX Appendix 4C Query
02/08/12PRICE SENSITIVE
UCMUSCOM used to reduce mortality in septic shock by 90%
02/08/12PRICE SENSITIVE
UCMAppendix 4C - quarterly
27/07/12PRICE SENSITIVE
UCMNew Substantial shareholding
20/07/12PRICE SENSITIVE
UCMGerman study endorses USCOM
05/06/12PRICE SENSITIVE
UCMNew UK NHS Guidelines
11/05/12PRICE SENSITIVE
UCMAppendix 4C Commentary
02/05/12PRICE SENSITIVE
UCMAppendix 4C - quarterly
30/04/12PRICE SENSITIVE
UCMUSCOM expands distribution
19/03/12PRICE SENSITIVE
UCMHalf Yearly Report and Accounts
23/02/12PRICE SENSITIVE
UCMAppendix 4C - quarterly
31/01/12PRICE SENSITIVE
UCMManagement restructure and operations update
07/12/11PRICE SENSITIVE
UCMBoard Appointments
25/11/11PRICE SENSITIVE
UCMTrading Halt
23/11/11PRICE SENSITIVE
UCMAppendix 4C - quarterly
31/10/11PRICE SENSITIVE
UCMPreliminary and Annual Report to shareholders
31/08/11PRICE SENSITIVE
UCMAppendix 4C - quarterly
27/07/11PRICE SENSITIVE
UCMUpdate on Full Year Results
13/07/11PRICE SENSITIVE
UCMUscom advances into Europe
13/05/11PRICE SENSITIVE
UCMAppendix 4C - quarterly
29/04/11PRICE SENSITIVE
UCMNew sales distributors in USA and Canada
13/04/11PRICE SENSITIVE
UCMHalf Yearly Report and Accounts
24/02/11PRICE SENSITIVE
UCMHalf year financial update
27/01/11PRICE SENSITIVE
UCMAppendix 4C - quarterly
27/01/11PRICE SENSITIVE
UCMUSCOM Share purchase plan
19/01/11PRICE SENSITIVE
UCMFinancial results update
14/01/11PRICE SENSITIVE
UCMKiely appointment and proposed private placement
02/12/10PRICE SENSITIVE
UCMAppendix 4C - quarterly
29/10/10PRICE SENSITIVE
UCMPreliminary and Annual Report to shareholders
31/08/10PRICE SENSITIVE
UCMStrategic Review of Sales and Distribution Channels
20/08/10PRICE SENSITIVE
UCMAppendix 4C - quarterly
20/07/10PRICE SENSITIVE
UCMNew US Patent for Uscom
27/04/10PRICE SENSITIVE
UCMAppendix 4C - quarterly
20/04/10PRICE SENSITIVE
UCMCanadian Regulatory Approval for USCOM
06/04/10PRICE SENSITIVE
UCMUSCOM publication on ICU fluid and septic shock
18/03/10PRICE SENSITIVE
UCMHalf Yearly Report and Accounts
09/02/10PRICE SENSITIVE
UCMAppendix 4C - quarterly
27/01/10PRICE SENSITIVE
UCMPresented at Rome Congress and European Users Meeting
21/12/09PRICE SENSITIVE
UCMTexas Childrens Hospital Adopts USCOM Technology
19/11/09PRICE SENSITIVE
UCMAppendix 4C - quarterly
20/10/09PRICE SENSITIVE
UCMSpacelabs Healthcare to Launch Uscom in the UK
25/09/09PRICE SENSITIVE
UCMUSCOM Allowed USA Pacemaker Optimisation Patent
04/09/09PRICE SENSITIVE
UCMPreliminary and Annual Report to shareholders
28/08/09PRICE SENSITIVE
UCMAppendix 4C - quarterly
28/07/09PRICE SENSITIVE
UCMFY09 Update
06/07/09PRICE SENSITIVE
UCMFurther 24 USCOM units ordered by Spacelabs Healthcare
22/06/09PRICE SENSITIVE
UCMUSCOM validated in pregnancy
20/04/09PRICE SENSITIVE
UCMAppendix 4C - quarterly
20/04/09PRICE SENSITIVE
UCMHalf Yearly Report and Accounts
27/02/09PRICE SENSITIVE
UCMAppendix 4C - quarterly
27/01/09PRICE SENSITIVE
UCMEchoscope - New US patent for Uscom
14/01/09PRICE SENSITIVE
UCMUSCOM - American Journal of Surgery Publication
18/12/08PRICE SENSITIVE
UCMStrategic Investment by NASDAQ Listed OSI Systems
17/12/08PRICE SENSITIVE
UCMUscom and Spacelabs Healthcare form strategic relationship
16/12/08PRICE SENSITIVE
(20min delay)
Last
3.2¢
Change
0.000(0.00%)
Mkt cap ! $3.506M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 150000 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
3.2¢ 200000 1
View Market Depth
Last trade - 16.12pm 29/11/2024 (20 minute delay) ?
UCM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.